Literature DB >> 10912490

Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study.

T Huo1, J C Wu, S J Hwang, C R Lai, P C Lee, S H Tsay, F Y Chang, S D Lee.   

Abstract

OBJECTIVE AND
DESIGN: Chronic hepatitis B virus (HBV) infection may lead to liver cirrhosis; however, factors associated with the development of cirrhosis have been incompletely studied. A total of 516 patients with chronic hepatitis B were followed up longitudinally to determine their outcome.
METHODS: The clinical and pathological features were compared between those with and without cirrhosis occurrence. The risk factors were analysed, and the probability of the development of cirrhosis was estimated.
RESULTS: During a mean follow-up period of 5.7 +/- 3.4 years (range 1-17 years), cirrhosis occurred in 71 patients, with a calculated annual incidence of 2.4%. Older age (> 45 years) at entry, male gender, persistent hepatitis (> 1.5-fold rise of serum alanine aminotransferase levels for at least one year) and diabetes mellitus were identified as independent risk factors of cirrhosis in a multivariate analysis (odds ratios 8.0, 19.3, 2.0 and 5.2, respectively; P values all < 0.05). A logistic regression equation was used to predict the probability of cirrhosis occurrence, which was as high as 76.6% when all risk factors were present. Acute exacerbation or super-infection by hepatitis C or D viruses were not significant predictors. Patients with subsequent cirrhosis had higher initial hepatic histological necro-inflammatory activities when compared to age- and sex-matched non-cirrhotic controls (Knodell's scores: 8.2 +/- 2.4 versus 6.0 +/- 4.1, P< 0.05).
CONCLUSIONS: Patients who were elderly, male, diabetic or had a history of persistent and histologically severe hepatitis were at increased risks of liver cirrhosis. Aggressive anti-viral therapy may be needed for these patients and they should be closely monitored for HBV-related late complications.

Entities:  

Mesh:

Year:  2000        PMID: 10912490     DOI: 10.1097/00042737-200012060-00019

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  16 in total

Review 1.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

2.  Effects of variant rs346473 in ARHGAP24 gene on disease progression of HBV infection in Han Chinese population.

Authors:  Lifeng Liu; Jinjian Yao; Jin Li; Jinliang Zhang; Jinling Yu; Xiaorui Jiang; Shuzhen Sun; Qing Liu; Ying Chang; Yongwen He; Jusheng Lin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

Review 3.  Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.

Authors:  Ichiro Shimizu; Nao Kohno; Katsuyoshi Tamaki; Masayuki Shono; Hui-Wei Huang; Jiang-Hong He; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

4.  [Long-term prognosis and quality of life of survivors with hepatitis B virus-related acute-on-chronic liver failure].

Authors:  Cong-Yan Zhu; Guan-Ting Lu; Ting-Ting Qi; Qin-Jun He; Yong-Peng Chen; Wei-Qun Wen; Fu-Yuan Zhou; Jin-Jun Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

5.  Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study.

Authors:  Oh Sang Kwon; Young Kul Jung; Yun Soo Kim; Sang Gyune Kim; Young Seok Kim; Jung Il Lee; Jin Woo Lee; Young Soo Kim; Byung Chul Chun; Ju Hyun Kim
Journal:  Korean J Hepatol       Date:  2010-09

Review 6.  Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C.

Authors:  Ye-Jiao Wu; Ming-Yi Xu; Lun-Gen Lu
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

7.  Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.

Authors:  Zhongxian Poh; Boon-Bee George Goh; Pik-Eu Jason Chang; Chee-Kiat Tan
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-06       Impact factor: 2.566

Review 8.  Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease.

Authors:  Zobair Younossi; Katrin Kochems; Marc de Ridder; Desmond Curran; Eveline M Bunge; Laurence de Moerlooze
Journal:  Hum Vaccin Immunother       Date:  2017-07-25       Impact factor: 3.452

9.  Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up.

Authors:  Shahnaz Sali; Seyed Moayed Alavian; Graham R Foster; Hossein Keyvani; Leila Mehrnoosh; Navid Mohammadi
Journal:  Hepat Mon       Date:  2013-07-08       Impact factor: 0.660

10.  Use of concomitant variceal embolization and prophylactic antiplatelet/anticoagulative in transjugular intrahepatic portosystemic shunting: A retrospective study of 182 cirrhotic portal hypertension patients.

Authors:  Yingmei Tang; Sheng Zheng; Jinhui Yang; Weimin Bao; Lihong Yang; Yingchun Li; Ying Xu; Jing Yang; Yuyun Tong; Jinhang Gao; Chengwei Tang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.